General Information of the Compound
| Compound ID |
CP0405091
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[8-(hydroxyamino)-8-oxooctanoyl]piperazine-1-carboxylate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H41N5O9
|
||||||||||||||||||
| Molecular Weight |
675.739
|
||||||||||||||||||
| Canonical SMILES |
CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCN(CC3)C(=O)CCCCCCC(=O)NO)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H41N5O9/c1-3-22-23-17-21(49-34(45)39-15-13-38(14-16-39)30(42)10-8-6-5-7-9-29(41)37-47)11-12-27(23)36-31-24(22)19-40-28(31)18-26-25(32(40)43)20-48-33(44)35(26,46)4-2/h11-12,17-18,46-47H,3-10,13-16,19-20H2,1-2H3,(H,37,41)/t35-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KRJLWDXXPHEJQA-DHUJRADRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound